A new report debunks Big Pharma’s rhetoric; the prices charged by hospitals for scans are all over the place; meanwhile, an increasing number of Americans skip out on care as a result of costs; and, a recent analysis shines a light on ER spending.
Changing the conversation surrounding “white-bagging”; hospital prices are anecdotally arbitrary; stakeholders come to the defense of the Medicare Advantage program; and, a new study shows Big Pharma spending more on marketing and promotion than R&D.
Stakeholders urge the Administration to move forward with their final rules addressing surprise medical bills; private equity interests drive tech investment in hospitals; a handful of drug price hikes drove up billions in healthcare spending last year; and, a majority of Medicaid managed care plans are now offering health equity benefits.
Thanksgiving is the perfect opportunity to say thank you for being a part of the Health Action Network. We hope you have a healthy and safe holiday with your family and friends.
Thanksgiving is the perfect opportunity to say thank you for being a part of the Health Action Network. We hope you have a healthy and safe holiday with your family and friends.
A new analysis finds that hospitals are making a lot of money on outpatient drugs; meanwhile, a separate study shows that better hospital efficiency would lead to billions of dollars in savings for Medicare; beneficiaries enrolled in Medicare Advantage plans have lower COVID hospitalization and mortality rates; and, a reminder to consumers that the annual open enrollment periods for Medicare and on the exchanges are underway.
Changing the conversation surrounding “white-bagging”; hospital prices are anecdotally arbitrary; stakeholders come to the defense of the Medicare Advantage program; and, a new study shows Big Pharma spending more on marketing and promotion than R&D.
The focus on high drug prices exposes hospitals’ role in driving up these costs; meanwhile, the average price of specialty drugs is found to be increasing faster than inflation; stakeholders support recently proposed final rules targeting surprise medical bills; and, a look at how private equity interests impact consumers’ healthcare costs.
The focus on high drug prices exposes hospitals’ role in driving up these costs; meanwhile, the average price of specialty drugs is found to be increasing faster than inflation; stakeholders support recently proposed final rules targeting surprise medical bills; and, a look at how private equity interests impact consumers’ healthcare costs.
Medicare Advantage plans expand benefits going into next year; a new poll details the impact of out-of-control prescription drug prices on Americans; the cost of treating COVID patients varies wildly; and, a growing body of research underscores how hospital consolidation affects healthcare prices.